Newly Revealed Cellular Pathway May Lead to Cancer Therapies
Credit: Destroyer of furries from Wikimedia Commons
Scientists have discovered a new cellular pathway that can promote and support the growth of cancer cells. In a mouse model of melanoma, blocking this pathway resulted in reduction of tumor growth. The study, which appears in Science, offers a novel opportunity to develop drugs that could potentially inhibit this pathway in human cancer cells and help control their growth.
“We had been studying components of this pathway for several years,” said senior author Dr. Andrea Ballabio, professor of molecular and human genetics at Baylor College of Medicine and Texas Children’s Hospital in Houston, Texas, and director of the Telethon Institute of Genetics and Medicine in Naples, Italy. “We know that the pathway is important for normal cells to carry their activities as it is involved in regulating metabolism, that is, how cells process nutrients to obtain energy and how cells use energy to grow. In this study we wanted to learn more about how the pathway regulates its activity.”
Pathways involved in cellular metabolism typically regulate themselves, meaning that some components of the pathway control each other’s activities. “We suspected that the pathway was autoregulated, and we confirmed it in this study. Our experimental approaches showed that there is a feedback loop within the path that allows it to control itself.”
An important pathway for normal cellular activities
Ballabio and his colleagues studied the role of the pathway in two normal cellular activities; how cells respond to physical exercise and how they respond to nutrient availability. In terms of physical exercise, the researchers determined that the self-regulating mechanism they discovered is essential for the body builder effect.
“Some athletes take the aminoacid leucine or a mixture of aminoacids immediately after exercising, which promotes protein synthesis that leads to muscle growth. This is the body builder effect,” Ballabio said. “When we genetically engineered mice to lack the pathway, we lost the body builder effect.”
The researchers had a group of normal mice and another of mice lacking the pathway. Both groups were set to exercise and fed leucine immediately after. While normal mice showed enhanced protein synthesis, the mice without the pathway did not.
“In healthy organisms, this pathway also allows cells to adapt more efficiently to nutrient availability,” Ballabio said. “For example, when transitioning from a period of starvation to one in which food is available, cells need to switch from catabolism to anabolism. Starvation promotes catabolism – the breakdown of nutrients to obtain energy to function – and eating promotes anabolism – the buildup of molecules, such as proteins. The feedback we discovered mediates the switch from catabolism to anabolism, allowing organisms to adapt to food availability.”
An important pathway for cancer growth
The scientists also studied the role this pathway might play in cancer cells. They discovered that overactivation of this pathway, which is observed in some types of cancer such as renal cell carcinoma, melanoma and pancreatic cancer, is important to promote and support the growth of cancer cells in culture and animal models.
“Most importantly, we demonstrated in our study that blocking the pathway resulted in reduction of tumor growth in an experimental model of human melanoma transplanted into mice,” Ballabio said. “I am most excited about the future potential therapeutic applications of this discovery against cancer. Developing pharmacological treatments that interfere with this pathway might one day help stop tumor growth.”
Rare disease discoveries can improve our understanding of common diseases
“Our lab focuses on rare genetic diseases, such as lysosomal storage genetic disorders, in which we originally studied this pathway,” Ballabio said. “Then, we discovered that the pathway is also important in cancer. Our and other researchers’ work on rare genetic diseases sometimes produces findings that can potentially be applicable to more common diseases, such as cancer.”
This article has been republished from materials provided by Baylor College of Medicine. Note: material may have been edited for length and content. For further information, please contact the cited source.
Malta, Chiara et al. "Transcriptional Activation Of Ragd Gtpase Controls Mtorc1 And Promotes Cancer Growth". Science.sciencemag.org. N.p., 2017. Web. 19 June 2017.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
BioAscent Announces New CEO and Plans to Expand Discovery Services OfferingNews
BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018